Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Frontiers Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia

Leukemia Drug Trial Reveals How Cancer Cells Resist Therapy

Targeting the undruggable: menin inhibitors ante portas

Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective - Cytotherapy

Cancers, Free Full-Text

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International

Leukemia: Definition, Types & Risk Factors

City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias

Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies